Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Acknowledgements

The 2026 International Congress wishes to acknowledge the following supporters to date:

 

Diamond Level

Platinum Level

 

 

 

 

Gold Level

  MARQUEE SPONSOR  

 

 

Silver Level

 MARQUEE SPONSOR  

 

 


  MARQUEE SPONSOR  

 


 


Bronze Level

ActualSignal
Advanced Brain Monitoring, Inc.
Amprion Inc.
Arvinas Operations, Inc.
Association of Movement Disorder
Advanced Practice Providers
AT&C Co., Ltd.
Celestra Health Systems
Dasher Neuroscience Inc.
Eisai Korea Inc.

Empatica
Ferrer
FHC, Inc.
Fulgent Genetics
Indivi
IntraBio
JSC Vilimed
NeuraLight
neuroClues
Neuron23

Paraxel International, LLC
Rishena Medical Co., Ltd
Roche -  MARQUEE SPONSOR 
SK Biopharmaceuticals
Sumitomo Pharma Co., Ltd. -
 MARQUEE SPONSOR 
uMed
uniQure
Vima Therapeutics


The International Parkinson and Movement Disorder Society® has received unrestricted medical education grants from the following companies in support of the International Congress of Parkinson's Disease and Movement Disorders® in Seoul, Korea: Supernus Pharmaceuticals, Inc. and Abbvie.